Tocqueville Asset Management’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-23,150	Closed	-$597K	–	737
2021 Q1	$597K	Buy	+23,150	New	+$1.02M	0.01%	521
2020 Q3	–	Sell	-13,625	Closed	-$660K	–	648
2020 Q2	$660K	Hold	13,625	–	–	0.01%	445
2020 Q1	$576K	Hold	13,625	–	–	0.01%	431
2019 Q4	$583K	Sell	13,625 -19,900	-59%	-$866K	0.01%	528
2019 Q3	$1.21M	Sell	33,525 -35,543	-51%	-$1.08M	0.02%	437
2019 Q2	$1.85M	Sell	69,068 -23,800	-26%	-$608K	0.02%	399
2019 Q1	$2.49M	Buy	92,868 +41,000	+79%	+$958K	0.03%	365
2018 Q4	$839K	Hold	51,868	–	–	0.01%	484
2018 Q3	$1.08M	Buy	51,868 +33,168	+177%	+$522K	0.01%	491
2018 Q2	$286K	Sell	18,700 -14,480	-44%	-$258K	﹤0.01%	704
2018 Q1	$746K	Buy	33,180 +2,020	+6%	+$55.9K	0.01%	549
2017 Q4	$938K	Sell	31,160 -14,100	-31%	-$451K	0.01%	516
2017 Q3	$1.71M	Sell	45,260 -55,300	-55%	-$1.8M	0.02%	469
2017 Q2	$2.81M	Buy	100,560 +610	+0.6%	+$18.2K	0.03%	376
2017 Q1	$3.44M	Buy	99,950 +6,675	+7%	+$236K	0.04%	350
2016 Q4	$2.69M	Sell	93,275 -31,850	-25%	-$843K	0.03%	371
2016 Q3	$3.98M	Buy	125,125 +12,725	+11%	+$431K	0.05%	324
2016 Q2	$3.65M	Buy	112,400 +16,750	+18%	+$561K	0.04%	334
2016 Q1	$2.67M	Buy	95,650 +41,660	+77%	+$908K	0.04%	361
2015 Q4	$1.93M	Buy	53,990 +1,750	+3%	+$61.7K	0.03%	431
2015 Q3	$1.73M	Buy	52,240 +1,200	+2%	+$49.9K	0.02%	464
2015 Q2	$2.14M	Buy	51,040 +100	+0.2%	+$3.87K	0.03%	458
2015 Q1	$1.66M	Buy	50,940 +12,140	+31%	+$417K	0.02%	504
2014 Q4	$1.23M	Buy	38,800 +15,000	+63%	+$425K	0.01%	543
2014 Q3	$589K	Hold	23,800	–	–	0.01%	582
2014 Q2	$538K	Buy	+23,800	New	+$497K	0.01%	707